Mystic Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.07M Sell
28,927
-187
-0.6% -$43.6K 1.64% 12
2025
Q4
$6.03M Sell
29,114
-1,857
-6% -$367K 1.36% 13
2025
Q3
$5.74M Buy
30,971
+60
+0.2% +$10.3K 1.3% 16
2025
Q2
$4.72M Sell
30,911
-52
-0.2% -$7.99K 1.14% 19
2025
Q1
$5.14M Buy
30,963
+169
+0.5% +$26.4K 1.35% 15
2024
Q4
$4.45M Buy
30,794
+11,170
+57% +$1.73M 1.19% 16
2024
Q3
$3.18M Buy
19,624
+79
+0.4% +$12.6K 1.2% 19
2024
Q2
$2.86M Buy
19,545
+11
+0.1% +$1.64K 1.15% 21
2024
Q1
$3.09M Buy
19,534
+1,288
+7% +$205K 1.28% 19
2023
Q4
$2.86M Buy
18,246
+437
+2% +$67K 1.37% 17
2023
Q3
$2.77M Sell
17,809
-285
-2% -$47K 1.56% 16
2023
Q2
$2.99M Sell
18,094
-200
-1% -$32.3K 1.61% 14
2023
Q1
$2.84M Sell
18,294
-95
-0.5% -$15.3K 1.56% 15
2022
Q4
$3.25M Sell
18,389
-31
-0.2% -$5.35K 1.85% 11
2022
Q3
$3.01M Sell
18,420
-195
-1% -$33K 1.93% 7
2022
Q2
$3.3M Buy
18,615
+850
+5% +$151K 2.01% 6
2022
Q1
$3.15M Sell
17,765
-160
-0.9% -$27.2K 1.69% 9
2021
Q4
$3.07M Buy
+17,925
New +$2.93M 1.45% 14

Other funds holding JNJ

Mystic Asset Management's JNJ Position: Q1 2026 in Review

Mystic Asset Management reduced its Johnson & Johnson (JNJ) stake by 0.64% in Q1 2026, selling an estimated $43.6K and leaving 28,927 shares worth $7.07M. The position accounts for 1.64% of the portfolio, ranked #12.

Mystic Asset Management first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Mystic Asset Management held 28,927 shares of Johnson & Johnson worth $7.07M as of Q1 2026.
  • Mystic Asset Management sold 187 Johnson & Johnson shares in Q1 2026, an estimated $43.6K.
  • Johnson & Johnson made up 1.64% of Mystic Asset Management's portfolio in Q1 2026, its #12 holding.
  • Mystic Asset Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Mystic Asset Management's 13F filing for Q1 2026, filed 8 May 2026.